TOMTEC-ARENA vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

TOMTEC-ARENA

by TOMTEC Imaging Systems GmbH

EchoNext

by Pathway Labs

AI Verdict

TOMTEC-ARENA is a broad, vendor-neutral platform for advanced medical image analysis, quantification, and reporting across cardiology and radiology, primarily utilizing modalities like ultrasound. EchoNext, on the other hand, is a specialized AI tool focused on analyzing standard ECGs to detect hidden structural heart disease, acting as a screening tool to identify patients who may need further imaging like echocardiograms. While both operate in cardiology AI, their primary input data, scope, and function differ significantly, making them complementary rather than direct competitors.

Choose TOMTEC-ARENA if…

Choose TOMTEC-ARENA if your institution requires a comprehensive, AI-powered, and vendor-neutral solution for advanced medical image analysis, quantification, and reporting across multiple modalities in cardiology and radiology. It is ideal for organizations needing flexible deployment options (on-premise, cloud-hybrid, client-server) and web-based workflows for efficient diagnostic processes and structured reporting.

View TOMTEC-ARENA →

Choose EchoNext if…

Choose EchoNext if your primary goal is early, cost-effective, and non-invasive screening for hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, using standard ECGs. This tool is particularly well-suited for broad access in various clinical settings, from major hospitals to community practices, to identify at-risk patients who may require further cardiac evaluation.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	TOMTEC-ARENA	EchoNext
Pricing	Contact vendor for pricing	Starts at $600/month
Deployment	On-premise (workstation), Cloud-hybrid (web-based access via TOMTEC ZERO), Client-server network	Available through the OpenEvidence clinical decision support platform.
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

TOMTEC-ARENA

TOMTEC-ARENA offers web-based diagnostic workflows (TOMTEC ZERO) that break down barriers of traditional workstations, allowing access to image review, analysis, and reporting via a web browser, which enhances flexibility and remote work capabilities. It also features AI-based measurement automation to reduce manual tasks and improve efficiency. EchoNext is available through the OpenEvidence platform, but specific details on its user interface or workflow efficiencies are not as extensively described.

Clinical Value

EchoNext

EchoNext has demonstrated superior accuracy in detecting structural heart disease from ECGs compared to cardiologists, even those assisted by AI, with an accuracy of 77% versus 64% (or 69% with AI assistance). It has also been credited with detecting previously undiagnosed heart failure that led to a heart transplant, highlighting its potential for life-saving early detection. While TOMTEC-ARENA offers advanced quantification and AI-based measurement automation for various cardiac and radiology applications, its clinical impact in terms of diagnostic superiority over human experts or direct patient outcome improvements is not as explicitly detailed in the provided information.

Pricing & Value

EchoNext

EchoNext provides clear tiered pricing starting at $600/month, including an annual discount and add-on options, offering transparency and predictable costs. TOMTEC-ARENA requires contacting the vendor for pricing, which, while offering flexible and tailored options, lacks initial transparency. EchoNext's clear pricing structure and demonstrated clinical impact for early disease detection offer a more tangible value proposition.

Enterprise Readiness

TOMTEC-ARENA

TOMTEC-ARENA offers flexible deployment options including on-premise, cloud-hybrid (via TOMTEC ZERO), and client-server network, along with DICOM connectivity and PACS/EMR integration, indicating robust enterprise compatibility. It also offers concurrent user licenses and automated archiving. EchoNext is available through the OpenEvidence platform, which is used by many physicians, but its broader integration capabilities and deployment flexibility within diverse enterprise IT environments are not as comprehensively detailed.

Innovation

EchoNext

EchoNext is highlighted as the world's first FDA-cleared AI tool for detecting hidden structural heart disease from standard ECGs across multiple conditions, representing a significant breakthrough in early cardiac screening. Its ability to identify conditions often missed by human cardiologists and its training on a massive dataset of ECG-echocardiogram pairs demonstrate cutting-edge AI application. TOMTEC-ARENA offers AI-based automation and web-based workflows, which are innovative, but EchoNext's specific diagnostic capability for early, hidden disease detection from a widely available test like ECG appears to be a more novel and impactful innovation.

Support & Docs

TOMTEC-ARENA

TOMTEC-ARENA explicitly mentions offering premium TOMTEC service with an Up-to-Date maintenance contract, consultation, implementation, configuration, education, and support, including quick guides and software updates. This indicates a comprehensive support structure. EchoNext's documentation does not detail its support and documentation offerings as extensively, focusing more on its clinical validation and deployment.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	TOMTEC-ARENA	EchoNext
Tool Name	TOMTEC-ARENA	EchoNext
Company	TOMTEC Imaging Systems GmbH	Pathway Labs
Description	AI-powered, multimodality, vendor-neutral software for advanced medical image analysis, quantification, and reporting, primarily for cardiology and radiology, with web-based workflows.	FDA-cleared AI tool that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
Primary Specialties	Cardiology, Radiology	Cardiology, Family Medicine, Hospital Medicine, Internal Medicine
Key Features	AI-based measurement automation and data analytics; Multimodality and vendor-neutral imaging and analysis; Web-based diagnostic workflows (TOMTEC ZERO); Advanced quantification for various medical specialties; Structured reporting capabilities; DICOM connectivity and PACS/EMR integration; Automated archiving and data management; Support for 2D, 3D, and 4D image data	AI-powered ECG analysis; Detection of hidden structural heart disease; Identifies heart failure risk; Screens for valve disease; Detects pulmonary hypertension indicators; Utilizes standard 12-lead ECGs; FDA-cleared technology; Non-invasive diagnostic support

Videos

Demos, reviews, and walkthroughs featuring TOMTEC-ARENA and EchoNext.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for cardiology and radiology, and what is the learning curve for physicians?

TOMTEC-ARENA is designed for multimodality and vendor-neutral imaging and analysis, aiming to streamline echocardiography workflows across an organization by providing consistent diagnostic capabilities on and off-cart, with AI-driven automated measurements. EchoNext, on the other hand, integrates through the OpenEvidence clinical decision support platform and focuses on analyzing standard ECGs to detect structural heart disease. While TOMTEC-ARENA offers an extensive educational program with e-learning modules and a TOMTEC Academy to support users, EchoNext's learning curve would likely involve understanding its AI-powered ECG analysis and how its findings integrate into existing diagnostic pathways for structural heart disease.

What is the depth of EHR integration for each tool, and how does this impact data flow and physician efficiency?

TOMTEC-ARENA offers DICOM connectivity and PACS/EMR integration, allowing for automated archiving and data management, and the import of measurements performed on the cart into worksheets or reports. EchoNext is available through the OpenEvidence clinical decision support platform, suggesting integration within that ecosystem for data flow. The depth of integration for both tools would influence how seamlessly patient data, AI analysis results, and reports are exchanged with the EHR, impacting physician efficiency by reducing manual data entry and improving access to comprehensive patient information.

What are the accuracy and sensitivity metrics for each tool in detecting relevant clinical conditions?

TOMTEC-ARENA emphasizes AI-driven automated measurements with high levels of accuracy and reduced inter- and intra-observer variability for repeatability and reproducibility in both 2D and 3D applications. EchoNext has demonstrated high accuracy in detecting structural heart disease, achieving an AUROC of 85% in internal tests and 78-80% in external validation, and in a study, it showed higher accuracy (77%) compared to cardiologists (64%) at baseline.

Beyond cardiology, what other specialties can benefit from these tools, and how do their features cater to those specialties?

TOMTEC-ARENA is a multimodality, vendor-neutral software primarily for cardiology and radiology, with solutions for adult and pediatric cardiology, obstetrics, gynecology, radiology, and vascular diagnostics, offering advanced quantification and structured reporting. EchoNext is specifically focused on cardiology, family medicine, hospital medicine, and internal medicine, by providing AI-powered ECG analysis to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.

What kind of support and educational resources are available to ensure effective utilization and ongoing proficiency with each tool?

TOMTEC-ARENA provides a premium TOMTEC service with an Up-to-Date maintenance contract, an exclusive Customer Care Program, and the TOMTEC Academy, which includes e-learning modules for self-study and monthly webinars on clinical topics and new solutions. EchoNext's support structure is not explicitly detailed, but its availability through the OpenEvidence platform suggests that support might be integrated with that platform's existing services.

Are there audit-trail features available to track user activity and data modifications within the tools?

While not explicitly detailed for either product, audit trail features are crucial for understanding clinical workflow and are often integrated into EHR systems for security and privacy purposes. Given that TOMTEC-ARENA offers automated archiving and data management, and EchoNext integrates with a clinical decision support platform, it is highly probable that both tools would incorporate audit-trail functionalities to track user interactions and data changes for accountability and compliance.